Lawmakers Challenge CMMI’s Fowler: Why Are Alternative Payment Models
Failing to Deliver Cost Savings?
The Center for Medicare and Medicaid Innovation (CMMI) is once again under
intense scrutiny. As lawmakers push for greater transparency and fiscal
accountability, CMMI Director Liz Fowler recently faced rigorous questioning
regarding the efficacy of Alternative Payment Models (APMs). For years, the
promise of value-based care has been touted as the panacea for soaring
healthcare costs. However, with mounting evidence suggesting that many of
these models are not delivering the promised savings, Congress is demanding a
strategic pivot.
The Core Conflict: Value-Based Care vs. Fiscal Reality
The fundamental premise of the Affordable Care Act's creation of CMMI was to
move healthcare away from the fee-for-service (FFS) model—which incentivizes
volume—toward a value-based system that rewards quality and outcomes. The
vision was compelling: reduce unnecessary procedures, improve patient
outcomes, and lower overall Medicare spending.
However, the transition has been fraught with challenges. During recent
congressional hearings, lawmakers expressed deep frustration that despite over
a decade of experimentation, the projected cost savings from many high-profile
APMs remain elusive. The debate centers on two primary questions:
- Are the current models fundamentally flawed in their design?
- Is the administrative burden and complexity overshadowing the clinical and financial benefits?
Congressional Concerns: Where Is the ROI?
Legislators from both sides of the aisle are pushing Director Fowler to
justify the continued investment in models that fail to produce net savings
for the Medicare Trust Fund. The scrutiny isn't just about the numbers; it is
about the long-term viability of the value-based care movement itself.
Key points of contention raised during the hearings include:
1. The Selection Bias Problem
Critics argue that CMMI often tests models with providers who are already
high-performing, leading to skewed results that don't translate when scaled to
the entire Medicare population. If models only work for the "best" providers,
they cannot be considered a solution to the broader system’s cost issues.
2. The Cost of Implementation
While models might show clinical improvements, the administrative costs
associated with participating in APMs often offset any savings achieved.
Lawmakers are concerned that CMS is spending more to manage these complex
programs than they are saving in healthcare delivery.
3. Lack of Transparency in Data
Lawmakers have criticized CMMI for a lack of transparency regarding the
internal evaluations of these models. There is a perception that failures are
quietly phased out without public accounting of why the specific design failed
to meet its cost-reduction benchmarks.
CMMI’s Perspective: It’s Not Just About Immediate Savings
Director Liz Fowler has consistently defended the innovation center by
highlighting that CMMI’s mission is twofold: testing new ways to pay for care
and improving the quality of that care. In her testimony, she emphasized that
while financial savings are a primary goal, they are not the only goal.
Fowler argued that many models demonstrate success in:
- Reducing hospital readmissions.
- Improving chronic disease management, particularly for diabetes and heart failure.
- Encouraging provider collaboration across care settings.
She emphasized that achieving structural shifts in the healthcare system takes
significant time. The "innovation" aspect of CMMI means some models will
inevitably fail, but these failures provide critical data to refine future
iterations.
What Needs to Change? Expert Insights
If APMs are to survive and thrive, stakeholders agree that a fundamental shift
is required in how CMMI approaches model design and evaluation. Experts
suggest the following improvements:
Standardization and Simplicity
The current landscape of APMs is dizzyingly complex, preventing many smaller
or rural practices from participating. Simplifying the reporting requirements
and standardizing quality measures would allow for broader adoption and better
comparisons across models.
Risk Adjustment Refinements
A persistent issue is risk adjustment. If models do not accurately account for
the complexity of the patients being treated, they create a perverse incentive
to avoid the sickest, most expensive patients—the very population the models
are intended to help.
Transitioning to Mandatory Participation
Some experts argue that the voluntary nature of most CMMI models is a major
contributor to their lack of broad impact. While mandatory models face
significant political opposition from provider groups, they may be necessary
to overcome selection bias and achieve system-wide savings.
Conclusion: A Crossroads for Value-Based Care
The dialogue between Congress and CMMI marks a critical turning point for
value-based care. Lawmakers are clearly losing patience with the slow pace of
fiscal results. For CMMI, the message is clear: the focus must shift from
experimentation for the sake of innovation toward rigorous, transparent, and
demonstrably effective models that produce measurable cost savings.
As the healthcare industry continues to grapple with the unsustainable
trajectory of Medicare spending, the pressure on Fowler and CMMI will only
intensify. Whether APMs can ultimately deliver on their promise remains an
open question, but the era of unquestioned support for these experiments has
ended.
FAQ
What is CMMI?
The Center for Medicare and Medicaid Innovation (CMMI) is a branch of the
Centers for Medicare & Medicaid Services (CMS) created by the Affordable Care
Act to test innovative payment and service delivery models to reduce program
expenditures while preserving or enhancing the quality of care.
Why are lawmakers concerned about APMs?
Lawmakers are concerned that despite significant investment, many Alternative
Payment Models have not demonstrated net cost savings for the Medicare
program. They are demanding more accountability and proof that these programs
are fiscally responsible.
What did Liz Fowler say in response to the criticism?
Director Fowler defended the work of CMMI, arguing that the mission includes
improving care quality and health outcomes, not just immediate financial
savings. She also noted that testing models inherently involves potential
failure and that these findings are crucial for future policy improvements.
Are all alternative payment models failing?
No. While many models have struggled to show net savings, some, particularly
those focused on specific disease management or high-cost patient populations,
have shown success in improving clinical outcomes and reducing total cost of
care for those specific cohorts.
What happens next?
Lawmakers are expected to push for more frequent reporting on model
performance, clearer metrics for success, and potential reforms in how CMMI
designs and selects future payment models.
Top comments (0)